ProfileGDS5678 / 1433267_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 10.8202680
GSM967853U87-EV human glioblastoma xenograft - Control 20.8203120
GSM967854U87-EV human glioblastoma xenograft - Control 30.8134430
GSM967855U87-EV human glioblastoma xenograft - Control 40.8011110
GSM967856U87-EV human glioblastoma xenograft - Control 50.8077960
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 10.8229770
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 20.8178960
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 30.8114650
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 40.809670
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 10.8203760
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 20.8115360
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 30.8126230
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 40.818020
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 50.8189460